Magnus Blix Award
For the Science publication on type 2 diabetes.
The record
The verifiable record
A single, source-anchored summary of Dr. Damon Tojjar's record across clinical medicine, research, drug development, and digital-health innovation. Each item is independently verifiable.
Clinical medicine
A physician's training and career, as documented.
Dr. Tojjar trained and worked as a physician across the full arc of clinical medicine. He completed a clinical internship (Forskar-AT) at Skane University Hospital in Lund and Malmo, with rotations in the emergency department, surgery (general, orthopedic, hand, breast, and melanoma), anesthesia and intensive care, urology, internal medicine, psychiatry, and primary care, and was the only graduate of his class offered a Skane University Hospital internship immediately, through a competitive interview.
He served as a junior doctor in orthopedic surgery, as a physician-scientist in the Department of Endocrinology at Skane University Hospital (Sweden's oldest department of endocrinology), and as a family physician in Swedish primary care, integrating outpatient practice with clinical research in diabetes and chronic-disease management. Alongside this he provided pro bono medical care for underprivileged people and refugees.
His formal clinical training evaluations across internal medicine, surgery, psychiatry, and general medicine were consistently rated Utmarkt (Outstanding), the highest mark, with particular strength noted in patient interaction, clinical examination, and diagnostic reasoning.
Peer-reviewed publications
Authored as Tojjar, D. Each links to its DOI.
- ScienceOverexpression of alpha2A-adrenergic receptors contributes to type 2 diabetesTojjar, D. (shared / co-second author). Magnus Blix Award.doi.org/10.1126/science.1176827
- Diabetes CareEthnic differences in the relationship between insulin sensitivity and insulin responseTojjar, D. (co-author). Systematic review and meta-analysis. Widely cited.doi.org/10.2337/dc12-1235
- DiabetologiaPolymorphisms in the Ca2+ channel CaV2.3 (CACNA1E) and type 2 diabetesTojjar, D. (co-author). Gene discovery and impaired insulin secretion.doi.org/10.1007/s00125-007-0846-2
- Diabetes, Obesity and MetabolismComparison of insulin degludec with insulin detemir in type 1 diabetesTojjar, D. (co-author). One-year treat-to-target trial.doi.org/10.1111/dom.12573
Awards and recognition
External issuers and recognition.
Medtech4Health Innovation Award
Awarded by Vinnova and Medtech4Health for the EASY Diabetes decision-support system.
Top 20 Deep Tech
European Institute of Innovation and Technology, recognizing Vi-Health.
Anna Lindh Fellowship
Held during his systems-medicine fellowship at Stanford University School of Medicine.
Education and training
Named institutions.
Ventures and clinical evaluation
Registry-anchored.
EASY Diabetes. An AI clinical decision-support system for type 2 diabetes, co-developed by Dr. Tojjar as Head of Medical and Science. It was evaluated in EASY-1, a registered randomized controlled trial (ClinicalTrials.gov NCT03258268), comparing the system against standard of care, and was recognized with the Medtech4Health Innovation Award.
Vi-Health. Co-founded by Dr. Tojjar; selected as one of 20 finalists (Top 20 Deep Tech) in the EIT Digital Challenge and later acquired by Numan.
Novo Nordisk, global development. International Medical Manager and Principal Medical Specialist, contributing to global clinical programs for diabetes therapies.
Where a claim has a public primary source (a DOI, an award listing, or a trial registry entry), this page links to it rather than restating figures, so each fact can be checked at the source.
In the words of colleagues
Independent recommendations, quoted with permission.
"His knowledge of the medical literature surpassed that of his peers, and his ability to use this knowledge within the clinical context benefitted patient flow. Damon's intellect, broad interests and interpersonal skills make him a valuable colleague."
"Great interest in orthopedics, good general medical knowledge and good judgment."
"I can warmly recommend him as a very capable colleague."
Quoted from recommendation letters, with the writers' permission.
Areas of expertise
Where he is a reference voice.
Evidence appraisal and research methodology
How to read a study, judge a clinical model, and tell trustworthy evidence from fragile evidence, across every field of medicine.
Drug development, GCP, and regulation
How medicines and devices are developed, tested, and regulated: global clinical development, Good Clinical Practice, and medical-device and software regulation (EU MDR, IVDR, FDA, SaMD).
Clinical decision support and healthcare AI
Building, validating, and governing AI that clinicians can trust, from the evidence to real-world use.
Diabetes genetics and metabolic science
Type 2 diabetes genetics, insulin secretion, and beta-cell biology: the peer-reviewed research foundation behind his broader work.
Dr. Tojjar writes and speaks as an explainer and a trusted evaluator of research and medical technology across medicine. He is available for expert perspectives, advisory, speaking, and media on these areas.
Contact
Get in touch.
For verification, collaboration, or media, reach out directly.